Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
9.95
+0.30 (3.11%)
Aug 14, 2025, 1:49 PM - Market open

Elicio Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-54.61-51.9-35.2-28.21-26.4-15.71
Upgrade
Depreciation & Amortization
1.151.181.171.060.250.19
Upgrade
Loss (Gain) From Sale of Assets
--00.110--
Upgrade
Stock-Based Compensation
2.011.451.180.580.620.3
Upgrade
Other Operating Activities
11.628.240.14.540.720.05
Upgrade
Change in Accounts Payable
2.81-3.330.021.130.031.12
Upgrade
Change in Other Net Operating Assets
1.937.29-0.08-1.280.84-2.66
Upgrade
Operating Cash Flow
-35.09-37.07-32.69-22.18-23.94-16.7
Upgrade
Capital Expenditures
-0.05-0.09-0.07-0.65-0.53-0.2
Upgrade
Sale of Property, Plant & Equipment
-00.03---
Upgrade
Investing Cash Flow
-0.05-0.08-0.03-0.65-0.53-0.2
Upgrade
Short-Term Debt Issued
-19.73--14.68-
Upgrade
Long-Term Debt Issued
--10---
Upgrade
Total Debt Issued
29.5919.7310-14.68-
Upgrade
Net Debt Issued (Repaid)
29.5919.7310-14.68-
Upgrade
Issuance of Common Stock
24.223.147.130.080.210.25
Upgrade
Repurchase of Common Stock
---0.15---
Upgrade
Other Financing Activities
-0.55-0.5521.64--0.44-
Upgrade
Financing Cash Flow
53.2442.3238.6121.219.3925.06
Upgrade
Foreign Exchange Rate Adjustments
0.170.02----
Upgrade
Net Cash Flow
18.285.195.89-1.63-5.078.16
Upgrade
Free Cash Flow
-35.13-37.16-32.76-22.83-24.46-16.9
Upgrade
Free Cash Flow Per Share
-2.50-3.04-6.48-72.26-1.60-1.57
Upgrade
Levered Free Cash Flow
-20.26-23.7-16.94-20.49-12.51-8.02
Upgrade
Unlevered Free Cash Flow
-19.8-23.42-16.28-18.24-11.96-8.02
Upgrade
Change in Working Capital
4.743.96-0.06-0.150.87-1.54
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q